Valstar Solution For Intravesical Use 40Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Valstar: Solution for intravesical use (40mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

VALRUBICIN (val ROO bi sin) is a chemotherapy drug. It is used to treat bladder cancer.

In-Depth Information
Select a Medication

Valstar 200mg/5ml Solution for Intravesical Instillation

NDC: 679790001
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bladder Cancer

Storage Information
Refrigerate (between 36 and 46 degrees F)
Do not freeze
Valstar 200mg/5ml Solution for Intravesical Instillation

Reported Side Effects for Valstar 200mg/5ml Solution for Intravesical Instillation

Tenesmus Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Fluid Retention Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.0-15.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Increased Blood Sugar Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
1.0-29.0%*
Severity: MODERATE
Onset: DELAYED
Peripheral Vasodilation Incidence:
2.0%*
Severity: MODERATE
Onset: RAPID
Vomiting Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Pain Of The Urethra Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Skin Rash Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Retaining Urine Incidence:
4.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Nighttime Urination Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Urine Discoloration Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Bladder Infection Incidence:
15.0%*
Severity: MODERATE
Onset: DELAYED
Uncontrolled Urination Incidence:
22.0%*
Severity: MODERATE
Onset: EARLY
Bladder Spasm Incidence:
31.0%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
56.0%*
Severity: MODERATE
Onset: EARLY
Urinary Urgency Incidence:
57.0%*
Severity: MILD
Onset: EARLY
Increased Urination Incidence:
61.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Valstar

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5